251 related articles for article (PubMed ID: 20406575)
1. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
[TBL] [Abstract][Full Text] [Related]
2. [The role of insulin-like growth factor-I gene expression abnormality in pathogenesis of diabetic peripheral neuropathy].
Li J; Wang C; Chen J; Li X; Feng Z; Ma H
Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):93-7. PubMed ID: 11798561
[TBL] [Abstract][Full Text] [Related]
3. The role of IGF-1 gene expression abnormality in pathogenesis of diabetic peripheral neuropathy.
Jianbo L; Chengya W; Jiawei C; Xiaolu L; Zhenqing F; Hongtai M
Chin Med Sci J; 2002 Dec; 17(4):204-9. PubMed ID: 12901506
[TBL] [Abstract][Full Text] [Related]
4. [Effect of xiaokeling concentration fluid on mRNA expression of insulin-like growth factor-1 in sciatic nerve of Streptozotocin-induced diabetic rats].
Zeng JZ; Dong KL; Li GC; Li LM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):49-52. PubMed ID: 15871187
[TBL] [Abstract][Full Text] [Related]
5. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
Sonobe M; Yasuda H; Hatanaka I; Terada M; Yamashita M; Kikkawa R; Shigeta Y
Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
[No Abstract] [Full Text] [Related]
6. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.
Zhuang HX; Wuarin L; Fei ZJ; Ishii DN
J Pharmacol Exp Ther; 1997 Oct; 283(1):366-74. PubMed ID: 9336345
[TBL] [Abstract][Full Text] [Related]
7. Early reduction in insulin-like growth factor gene expression in diabetic nerve.
Wuarin L; Guertin DM; Ishii DN
Exp Neurol; 1994 Nov; 130(1):106-14. PubMed ID: 7821385
[TBL] [Abstract][Full Text] [Related]
8. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
9. The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats.
Yao H; Feng J; Zheng Q; Wei Y; Wang S; Feng W
Life Sci; 2016 Sep; 161():60-8. PubMed ID: 27496624
[TBL] [Abstract][Full Text] [Related]
10. Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats.
Mizukami H; Ogasawara S; Yamagishi S; Takahashi K; Yagihashi S
Eur J Clin Invest; 2011 Apr; 41(4):442-50. PubMed ID: 21128935
[TBL] [Abstract][Full Text] [Related]
11. Effect of lacidipine pre-treatment on diabetic neuropathy in rats.
Singh J; Aditya S; Lal H; Arora B
Arch Physiol Biochem; 2011 Feb; 117(1):12-7. PubMed ID: 21091185
[TBL] [Abstract][Full Text] [Related]
12. Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine.
Saini AK; Arun KH; Kaul CL; Sharma SS
Pharmacol Res; 2004 Dec; 50(6):593-9. PubMed ID: 15501697
[TBL] [Abstract][Full Text] [Related]
13. Microvessel permeability correlates with diabetic peripheral neuropathy in early stage of streptozotocin-induced diabetes rats.
Peng L; Liu W; Zhai F; He L; Wang H
J Diabetes Complications; 2015; 29(7):865-71. PubMed ID: 26150384
[TBL] [Abstract][Full Text] [Related]
14. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN).
Baum P; Kosacka J; Estrela-Lopis I; Woidt K; Serke H; Paeschke S; Stockinger M; Klöting N; Blüher M; Dorn M; Classen J; Thiery J; Bechmann I; Toyka KV; Nowicki M
Metabolism; 2016 Apr; 65(4):391-405. PubMed ID: 26975531
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 Protects the Peripheral Nerve in Diabetics through Preventing Vascular Permeability Changes.
Mo F; Hu G; Liu W; He L; Wang H
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):113-122. PubMed ID: 28954306
[TBL] [Abstract][Full Text] [Related]
16. Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes.
Li JB; Wang CY; Chen JW; Feng ZQ; Ma HT
World J Gastroenterol; 2004 Jan; 10(2):255-9. PubMed ID: 14716834
[TBL] [Abstract][Full Text] [Related]
17. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
18. Comparison of peripheral nerve damages according to glucose control timing in experimental diabetes.
Jin HY; Kang SM; Liu WJ; Song CH; Lee KA; Baek HS; Park TS
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):451-9. PubMed ID: 22689102
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.
Samii A; Unger J; Lange W
Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880
[TBL] [Abstract][Full Text] [Related]
20. Near nerve local insulin prevents conduction slowing in experimental diabetes.
Singhal A; Cheng C; Sun H; Zochodne DW
Brain Res; 1997 Jul; 763(2):209-14. PubMed ID: 9296561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
